Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab
- 11 May 2020
- journal article
- editorial
- Published by Wiley in American Journal of Hematology
- Vol. 95 (7), 876-878
- https://doi.org/10.1002/ajh.25833
Abstract
No abstract availableFunding Information
- This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
This publication has 7 references indexed in Scilit:
- COVID-19: consider cytokine storm syndromes and immunosuppressionThe Lancet, 2020
- Extracorporeal Life Support for Severe Acute Chest Syndrome in Adult Sickle Cell Disease: A Preliminary ReportCritical Care Medicine, 2019
- Inflammation in sickle cell diseaseClinical Hemorheology and Microcirculation, 2018
- Severe pandemic H1N1 and seasonal influenza in children and young adults with sickle cell diseaseBlood, 2010
- Burden of Influenza-Related Hospitalizations Among Children With Sickle Cell DiseasePEDIATRICS, 2010
- Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell DiseaseNew England Journal of Medicine, 2000
- Serum Interleukin-6 Levels in the Steady State of Sickle Cell DiseaseJournal of Interferon & Cytokine Research, 1995